longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

United Therap

UTHR

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 16.01, below the reasonable range, cheaper than 82.82% of the time in the past 1 years, and the industry ranks 35/602, the industry Median -2.33.

16.01xP/E
$489.42Stock price
$30.56Earnings per share
16.01xP/E
Stock price$489.42Earnings per share$30.56

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
16.87x
Typical range
16.04x–18.13x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
019385776

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
AMGNUSAmgen
25.11x11.14%$219.55B
VRTXUSVertex Pharma
29.71x36.49%$130.87B
REGNUSRegeneron Pharma
19.07x5.79%$82.55B
INCYUSIncyte
15.67x65.04%$25.26B
GMABUSGenmab A/S
27.12x24.93%$21.37B
UTHRUSUnited Therap
16.01x6.53%$20.99B
ASNDUSAscendis Pharmac
17.05x477.43%$14.68B
NBIXUSNeurocrine Biosciences
20.10x50.16%$14.18B
EXELUSExelixis
16.33x16.46%$14.06B
TGTXUSTG Therap
19.42x65.83%$8.57B
CDNAUSCaredex
25.31x629.58%$2.81B
KMDAUSKamada
22.74x39.29%$506.12M
PBYIUSPuma BioTech
17.93x37.70%$479.03M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.